Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Indented intrathecal drug delivery system with loss of reservoir volume.

Goel V, Patwardhan AM, Ibrahim M, Shankar H, Schultz DM.

Reg Anesth Pain Med. 2019 May 12. pii: rapm-2019-100516. doi: 10.1136/rapm-2019-100516. [Epub ahead of print]

PMID:
31085577
2.

Complications associated with stellate ganglion nerve block: a systematic review.

Goel V, Patwardhan AM, Ibrahim M, Howe CL, Schultz DM, Shankar H.

Reg Anesth Pain Med. 2019 Apr 16. pii: rapm-2018-100127. doi: 10.1136/rapm-2018-100127. [Epub ahead of print] Review.

PMID:
30992414
3.

Targeting the CaVα-CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy.

Khanna R, Yu J, Yang X, Moutal A, Chefdeville A, Gokhale V, Shuja Z, Chew LA, Bellampalli SS, Luo S, François-Moutal L, Serafini MJ, Ha T, Perez-Miller S, Park KD, Patwardhan AM, Streicher JM, Colecraft HM, Khanna M.

Pain. 2019 Jul;160(7):1644-1661. doi: 10.1097/j.pain.0000000000001524.

PMID:
30933958
4.

In Reply.

Garami A, Ibrahim M, Gilbraith K, Khanna R, Pakai E, Miko A, Pinter E, Romanovsky AA, Porreca F, Patwardhan AM.

Anesthesiology. 2018 Aug;129(2):378-379. doi: 10.1097/ALN.0000000000002294. No abstract available.

PMID:
30020181
5.

Transient Receptor Potential Vanilloid 1 Antagonists Prevent Anesthesia-induced Hypothermia and Decrease Postincisional Opioid Dose Requirements in Rodents.

Garami A, Ibrahim M, Gilbraith K, Khanna R, Pakai E, Miko A, Pinter E, Romanovsky AA, Porreca F, Patwardhan AM.

Anesthesiology. 2017 Nov;127(5):813-823. doi: 10.1097/ALN.0000000000001812.

PMID:
28806222
6.

Receptor and channel heteromers as pain targets.

Berg KA, Patwardhan AM, Akopian AN.

Pharmaceuticals (Basel). 2012 Feb 23;5(3):249-78. doi: 10.3390/ph5030249.

7.

Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.

Berg KA, Rowan MP, Sanchez TA, Silva M, Patwardhan AM, Milam SB, Hargreaves KM, Clarke WP.

J Pharmacol Exp Ther. 2011 Jul;338(1):92-9. doi: 10.1124/jpet.110.177493. Epub 2011 Apr 12.

8.

Desensitization of transient receptor potential ankyrin 1 (TRPA1) by the TRP vanilloid 1-selective cannabinoid arachidonoyl-2 chloroethanolamine.

Ruparel NB, Patwardhan AM, Akopian AN, Hargreaves KM.

Mol Pharmacol. 2011 Jul;80(1):117-23. doi: 10.1124/mol.110.068940. Epub 2011 Mar 25.

9.

Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents.

Patwardhan AM, Akopian AN, Ruparel NB, Diogenes A, Weintraub ST, Uhlson C, Murphy RC, Hargreaves KM.

J Clin Invest. 2010 May;120(5):1617-26. doi: 10.1172/JCI41678. Epub 2010 Apr 26.

10.

Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia.

Patwardhan AM, Scotland PE, Akopian AN, Hargreaves KM.

Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18820-4. doi: 10.1073/pnas.0905415106. Epub 2009 Oct 20.

11.

A-kinase anchoring protein 150 controls protein kinase C-mediated phosphorylation and sensitization of TRPV1.

Jeske NA, Patwardhan AM, Ruparel NB, Akopian AN, Shapiro MS, Henry MA.

Pain. 2009 Dec;146(3):301-7. doi: 10.1016/j.pain.2009.08.002. Epub 2009 Sep 19.

12.

Peripheral delta opioid receptors require priming for functional competence in vivo.

Rowan MP, Ruparel NB, Patwardhan AM, Berg KA, Clarke WP, Hargreaves KM.

Eur J Pharmacol. 2009 Jan 14;602(2-3):283-7. doi: 10.1016/j.ejphar.2008.11.028. Epub 2008 Nov 25.

13.

Fibronectin stimulates TRPV1 translocation in primary sensory neurons.

Jeske NA, Patwardhan AM, Henry MA, Milam SB.

J Neurochem. 2009 Feb;108(3):591-600. doi: 10.1111/j.1471-4159.2008.05779.x. Epub 2008 Nov 11.

14.

Homologous and heterologous desensitization of capsaicin and mustard oil responses utilize different cellular pathways in nociceptors.

Ruparel NB, Patwardhan AM, Akopian AN, Hargreaves KM.

Pain. 2008 Apr;135(3):271-9. Epub 2007 Jun 27.

15.

Rapid modulation of micro-opioid receptor signaling in primary sensory neurons.

Berg KA, Patwardhan AM, Sanchez TA, Silva YM, Hargreaves KM, Clarke WP.

J Pharmacol Exp Ther. 2007 Jun;321(3):839-47. Epub 2007 Mar 8.

PMID:
17347322
16.

Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons.

Jeske NA, Patwardhan AM, Gamper N, Price TJ, Akopian AN, Hargreaves KM.

J Biol Chem. 2006 Oct 27;281(43):32879-90. Epub 2006 Sep 5.

17.

Prolactin modulates TRPV1 in female rat trigeminal sensory neurons.

Diogenes A, Patwardhan AM, Jeske NA, Ruparel NB, Goffin V, Akopian AN, Hargreaves KM.

J Neurosci. 2006 Aug 2;26(31):8126-36.

18.

The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin.

Patwardhan AM, Jeske NA, Price TJ, Gamper N, Akopian AN, Hargreaves KM.

Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11393-8. Epub 2006 Jul 18.

19.

PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor.

Patwardhan AM, Diogenes A, Berg KA, Fehrenbacher JC, Clarke WP, Akopian AN, Hargreaves KM.

Pain. 2006 Nov;125(1-2):114-24. Epub 2006 Jun 14.

PMID:
16781076
20.

Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors.

Patwardhan AM, Berg KA, Akopain AN, Jeske NA, Gamper N, Clarke WP, Hargreaves KM.

J Neurosci. 2005 Sep 28;25(39):8825-32.

Supplemental Content

Loading ...
Support Center